Pleading for phase V clinical trials in oncology

被引：0
|
作者：
Gligorov, J. [1 ]
Debrix, I.
Boelle, P. -Y. [2 ]
Flahault, A. [1 ]
机构：
[1] Univ Paris 06, APHP Tenon, INSERM, Unite Sante Publ,U707, F-75970 Paris 20, France
[2] Univ Paris 06, APHP St Antoine, INSERM, Unite Sante Publ,U707, F-75012 Paris, France
来源：
ONCOLOGIE | 2008年 / 10卷
关键词：
D O I：
10.1007/s10269-008-0886-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S97 / S99
页数：3
相关论文
共 50 条
  • [41] Pharmacogenomics in Early-Phase Oncology Clinical Trials: Is There a Sweet Spot in Phase II?
    O'Donnell, Peter H.
    Stadler, Walter M.
    CLINICAL CANCER RESEARCH, 2012, 18 (10) : 2809 - 2816
  • [42] Crossover in oncology clinical trials
    Diaz, Jose
    Sternberg, Cora N.
    Mehmud, Faisal
    Delea, Thomas E.
    Latimer, Nicholas
    Bartlett-Pandite, Arundathy N.
    Motzer, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] Clinical trials of interventional oncology
    Arai, Yasuaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (04) : 301 - 305
  • [44] Clinical trials in neurosurgical oncology
    Murphy, Meghan
    Parney, Ian F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 119 (03) : 569 - 576
  • [45] A compendium of unpublished phase III clinical trials in oncology: Characteristics and impact on clinical practice
    Tam, V. C.
    Tannock, I.
    Rauw, J.
    Krzyzanowska, M. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Endpoints in oncology clinical trials
    Kilickap, Saadettin
    Demirci, Umut
    Karadurmus, Nuri
    Dogan, Mutlu
    Akinci, Bulent
    Sendur, Mehmet Ali Nahit
    JOURNAL OF BUON, 2018, 23 : S1 - S6
  • [47] Adaptive clinical trials in oncology
    Berry, Donald A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (04) : 199 - 207
  • [48] Clinical Trials in Precision Oncology
    Mockus, Susan M.
    Patterson, Sara E.
    Statz, Cara
    Bult, Carol J.
    Tsongalis, Gregory J.
    CLINICAL CHEMISTRY, 2016, 62 (03) : 442 - 448
  • [49] Endpoints of clinical trials in oncology
    Roila, F
    Del Favero, A
    Ballatori, E
    TUMORI JOURNAL, 1997, 83 (06): : S8 - S13
  • [50] Bayesian optimal interval design for phase I oncology clinical trials
    Fellman, Bryan M.
    Yuan, Ying
    STATA JOURNAL, 2015, 15 (01) : 110 - 120
12345